文献速递区域麻醉与超声心胸血管麻醉疼痛医学

地塞米松与右美托咪定作为肋间神经阻滞佐剂在胸腔镜肺切除术中的随机研究

Dexamethasone and dexmedetomidine as adjuvants to local anesthetic mixture in intercostal nerve block for thoracoscopic pneumonectomy: a prospective randomized study.
PubMed 文献 · Reg Anesth Pain Med · 2019-08-08

结果显示联合用药组镇痛持续时间最长、术后芬太尼消耗量最低,且四组不良反应发生率无显著差异。

要点

  • 联合神经周围地塞米松与右美托咪定可显著延长肋间神经阻滞镇痛时间至824.2±105.1分钟。
  • 联合用药组术后芬太尼总消耗量最低(106.0±84.0 µg)。
  • 四组不良反应发生率无显著差异,联合方案安全性可接受。

核心结论

  • 在罗哌卡因肋间神经阻滞中加入神经周围右美托咪定与地塞米松联合用药,似为延长镇痛且几乎无不良反应的可行方法。

研究设计与样本

  • 肋间神经阻滞由外科医生在胸腔镜直视下完成,共涉及6个肋间隙,每处注射5 mL。

主要发现

  • 镇痛持续时间RSM组(824.2±105.1 min)长于RS组(611.5±133.0 min)、RM组(602.5±108.5 min)和R组(440.0±109.6 min),p<0.001。
  • 术后芬太尼总消耗量RSM组(106.0±84.0 µg)低于RS组(243.0±175.2 µg)、RM组(237.0±98.7 µg)和R组(369.0±134.2 µg),p<0.001。
  • 四组不良反应发生率无显著差异。

关键数值与推荐

  • R组:28 mL 0.5%罗哌卡因+2 mL生理盐水。
  • RS组:28 mL 0.5%罗哌卡因+10 mg地塞米松(2 mL)。
  • RM组:28 mL 0.5%罗哌卡因+1 µg/kg右美托咪定(2 mL)。
  • RSM组:28 mL 0.5%罗哌卡因+1 µg/kg右美托咪定+10 mg地塞米松(2 mL)。

临床怎么用

  • 胸腔镜肺切除术行肋间神经阻滞时,可考虑在罗哌卡因中加入右美托咪定与地塞米松联合佐剂以延长镇痛并减少术后阿片类消耗。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: Perineural dexamethasone or dexmedetomidine prolongs the duration of single-injection peripheral nerve block when added to the local anesthetic solution. In a randomized, controlled, double-blinded study in patients undergoing thoracoscopic pneumonectomy, we tested the hypothesis that combined perineural dexamethasone and dexmedetomidine prolonged the duration of analgesia as compared with either perineural dexamethasone or perineural dexmedetomidine after intercostal nerve block (INB). METHODS: Eighty patients were randomized to receive INB using 28 mL 0.5% ropivacaine, with 2 mL normal saline (R group), with 10 mg dexamethasone in 2 mL (RS group) or 1 µg/kg dexmedetomidine in 2 mL (RM group), or with 1 µg/kg dexmedetomidine and 10 mg dexamethasone in 2 mL (RSM group) administrated perineurally. The INB was performed by the surgeon under thoracoscopic direct vision; a total of six intercostal spaces were involved, each with an injection of 5 mL. The primary outcome was the duration of analgesia. Secondary outcomes included total postoperative fentanyl consumption, visual analog scale pain score and safety assessment (adverse effects). RESULTS: The duration of analgesia in RSM (824.2±105.1 min) was longer than that in RS (611.5±133.0 min), RM (602.5±108.5 min) and R (440.0±109.6 min) (p<0.001). Total postoperative fentanyl consumption was lower in RSM (106.0±84.0 µg) compared with RS (243.0±175.2 µg), RM (237.0±98.7 µg) and R (369.0±134.2 µg) (p<0.001). No significant difference was observed in the incidences of adverse effects between the four groups. CONCLUSION: The addition of combined perineural dexmedetomidine and dexamethasone to ropivacaine for INB seemed to be an attractive method for prolonged analgesia with almost no adverse effects. TRIAL REGISTRATION NUMBER: ChiCTR-IOR-17012183.

来源:Reg Anesth Pain Med,查看原文。版权归原作者所有。

引用

  1. Zhang P, Liu S, Zhu J, et al. Dexamethasone and dexmedetomidine as adjuvants to local anesthetic mixture in intercostal nerve block for thoracoscopic pneumonectomy: a prospective randomized study. Reg Anesth Pain Med. 2019. PMID: 31399540. doi:10.1136/rapm-2018-100221

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。